Literature DB >> 17175022

Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells.

Julian R Jones1, Olga Tsigkou, Emily E Coates, Molly M Stevens, Julia M Polak, Larry L Hench.   

Abstract

Sol-gel derived bioactive glasses of the 70S30C (70mol% SiO2, 30mol% CaO) composition have been foamed to produce 3D bioactive scaffolds with hierarchical interconnected pore morphologies similar to trabecular bone. The aim of this study was to investigate primary human osteoblast response to porous bioactive glass scaffolds. The scaffolds supported osteoblast growth and induced differentiation, within the 3-week culture period, as depicted by enhanced ALPase enzymatic activity, without the addition of supplementary factors such as ascorbic acid, beta-glycerophosphate and dexamethasone. This is the first time this has been observed on a bioactive glass that does not contain phosphate. Deposition of extracellular matrix was also confirmed by enhanced production of the extracellular matrix protein collagen type I. SEM showed indications of mineralized bone nodule formation without the addition of growth factors. The 70S30C bioactive glass scaffolds therefore fulfil many of the criteria for an ideal scaffold for bone tissue engineering applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17175022     DOI: 10.1016/j.biomaterials.2006.11.022

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  32 in total

1.  Effective combination of aligned nanocomposite nanofibers and human unrestricted somatic stem cells for bone tissue engineering.

Authors:  Behnaz Bakhshandeh; Masoud Soleimani; Nasser Ghaemi; Iman Shabani
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

2.  Enhanced osteointegration of orthopaedic implant gradient coating composed of bioactive glass and nanohydroxyapatite.

Authors:  Xin-Hui Xie; Xiao-Wei Yu; Shao-Xian Zeng; Rui-Lin Du; Yu-Huai Hu; Zhen Yuan; Er-Yi Lu; Ke-Rong Dai; Ting-Ting Tang
Journal:  J Mater Sci Mater Med       Date:  2010-04-09       Impact factor: 3.896

Review 3.  Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression.

Authors:  Kyobum Kim; Andrew Yeatts; David Dean; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

4.  Sol-gel method to fabricate CaP scaffolds by robocasting for tissue engineering.

Authors:  Manuel Houmard; Qiang Fu; Eduardo Saiz; Antoni P Tomsia
Journal:  J Mater Sci Mater Med       Date:  2012-02-07       Impact factor: 3.896

5.  Mineralization of osteoblasts with electrospun collagen/hydroxyapatite nanofibers.

Authors:  J Venugopal; Sharon Low; Aw Tar Choon; T S Sampath Kumar; S Ramakrishna
Journal:  J Mater Sci Mater Med       Date:  2007-10-24       Impact factor: 3.896

6.  Electrospun submicron bioactive glass fibers for bone tissue scaffold.

Authors:  H Lu; T Zhang; X P Wang; Q F Fang
Journal:  J Mater Sci Mater Med       Date:  2008-11-20       Impact factor: 3.896

7.  Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application.

Authors:  Chengtie Wu; Jiang Chang
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

8.  A porous scaffold for bone tissue engineering/45S5 Bioglass derived porous scaffolds for co-culturing osteoblasts and endothelial cells.

Authors:  Sanjukta Deb; Ramin Mandegaran; Lucy Di Silvio
Journal:  J Mater Sci Mater Med       Date:  2009-11-29       Impact factor: 3.896

Review 9.  Quantifying the 3D macrostructure of tissue scaffolds.

Authors:  Julian R Jones; Robert C Atwood; Gowsihan Poologasundarampillai; Sheng Yue; Peter D Lee
Journal:  J Mater Sci Mater Med       Date:  2008-10-07       Impact factor: 3.896

Review 10.  Cell culture systems for studies of bone and tooth mineralization.

Authors:  Adele L Boskey; Rani Roy
Journal:  Chem Rev       Date:  2008-09-19       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.